wet macular degeneration
Selected indexed studies
- Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema. (Curr Opin Ophthalmol, 2025) [PMID:39937692]
- Recent Developments in the Treatment of Wet Age-related Macular Degeneration. (Curr Med Sci, 2020) [PMID:32980899]
- Different Therapeutic Approaches for Dry and Wet AMD. (Int J Mol Sci, 2024) [PMID:39684764]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dry and neovascular "wet" age-related macular degeneration: Upcoming therapies. (2025) pubmed
- Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema. (2025) pubmed
- Recent Developments in the Treatment of Wet Age-related Macular Degeneration. (2020) pubmed
- Different Therapeutic Approaches for Dry and Wet AMD. (2024) pubmed
- Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment. (2022) pubmed
- Metabolic Regulation of Endothelial Cells: A New Era for Treating Wet Age-Related Macular Degeneration. (2024) pubmed
- Risk factors for wet macular degeneration: a systematic review, with novel insights from the Scottish Heart Health Extended Cohort. (2025) pubmed
- Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration. (2020) pubmed
- Effect of cataract surgery on wet age-related macular degeneration activity. (2022) pubmed
- Psychological impact of anti-VEGF treatments for wet macular degeneration-a review. (2016) pubmed